Clinical & Experimental Allergy

Cover image for Clinical & Experimental Allergy

December 1998

Volume 28, Issue S6

Pages 1–61

  1. Introduction

    1. Top of page
    2. Introduction
    3. Original Article
    1. Chairmen’s introduction (page 1)

      Bousquet and Davies

      Version of Record online: 4 JAN 2002 | DOI: 10.1046/j.1365-2222.1998.0280s6001.x

  2. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    1. Is allergy increasing? – early life influences (pages 2–7)

      Howarth

      Version of Record online: 4 JAN 2002 | DOI: 10.1046/j.1365-2222.1998.0280s6002.x

    2. Why is allergy increasing? – environmental factors (pages 8–14)

      Davies, Rusznak and Devalia

      Version of Record online: 4 JAN 2002 | DOI: 10.1046/j.1365-2222.1998.0280s6008.x

    3. Histamine – a major role in allergy? (pages 15–19)

      Bachert

      Version of Record online: 4 JAN 2002 | DOI: 10.1046/j.1365-2222.1998.0280s6015.x

    4. The inflammatory nature of allergic disease (pages 20–24)

      Durham

      Version of Record online: 4 JAN 2002 | DOI: 10.1046/j.1365-2222.1998.0280s6020.x

    5. Allergic rhinitis – making the correct diagnosis (pages 25–28)

      Lund

      Version of Record online: 4 JAN 2002 | DOI: 10.1046/j.1365-2222.1998.0280s6025.x

    6. Management of rhinitis – the specialist’s opinion (pages 29–33)

      Van Cauwenberge

      Version of Record online: 4 JAN 2002 | DOI: 10.1046/j.1365-2222.1998.0280s6029.x

    7. Rhinitis management: the patient’s perspective (pages 34–38)

      Juniper

      Version of Record online: 4 JAN 2002 | DOI: 10.1046/j.1365-2222.1998.0280s6034.x

    8. Allergic eye disease – a clinical challenge (pages 39–43)

      Buckley

      Version of Record online: 4 JAN 2002 | DOI: 10.1046/j.1365-2222.1998.0280s6039.x

    9. Treating severe eye allergy (pages 44–48)

      Verin

      Version of Record online: 4 JAN 2002 | DOI: 10.1046/j.1365-2222.1998.0280s6044.x

    10. Antihistamines in severe/chronic rhinitis (pages 49–53)

      Bousquet

      Version of Record online: 4 JAN 2002 | DOI: 10.1046/j.1365-2222.1998.0280s6049.x

    11. Optimizing treatment options (pages 54–59)

      Naclerio

      Version of Record online: 4 JAN 2002 | DOI: 10.1046/j.1365-2222.1998.0280s6054.x

    12. Chairmen’s concluding remarks (pages 60–61)

      Bousquet and Davies

      Version of Record online: 4 JAN 2002 | DOI: 10.1046/j.1365-2222.1998.0280s6060.x

SEARCH

SEARCH BY CITATION